Amgen and Astellas Pharma agreed to pay $124.75 million total ($100 million for Astellas and $24.75 million for Amgen) after they were accused of using multiple foundations to induce Medicare patients to purchase the company’s drugs. https://www.raps.org/news-and-articles/news-articles/2019/4/amgen-astellas-pharma-pay-125m-to-settle-doj-kic
